XTLB
XTL Biopharmaceuticals Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.53
+1.20%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.14x
- Price / sales
- 13.79x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $5.2M
- EV / sales
- 11.56x
- EV / EBITDA
- -6.59x
- EV / EBIT
- -2.40x
- Market cap
- $6.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025